AHPIQ — Allied Healthcare Products Share Price
Last trade - 00:00- $0.00m
- $7.25m
- $27.05m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0 | ||
| Price to Tang. Book | 0 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -33.46% | ||
| Return on Equity | -67.81% | ||
| Operating Margin | -16.93% | ||
Financial Summary
| Year End 30th Jun | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 33.76 | 31.38 | 31.89 | 36.28 | 27.05 | n/a | n/a | -4.2% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Allied Healthcare Products Inc. has filed a voluntary petition under Chapter 11 of the U.S. Bankruptcy Code and is winding down its business. The Company has no business operations.
Directors
- John Weil NEC (80)
- Joseph Ondrus PRE (64)
- Daniel Dunn CFO (62)
- Susan Deuser IND (75)
- Judith Graves IND (74)
- Joseph Root IND (76)
- Last Annual
- June 30th, 2022
- Last Interim
- June 30th, 2022
- Incorporated
- December 19th, 1979
- Public Since
- January 14th, 1992
- No. of Shareholders
- 34
- No. of Employees
- 146
- Sector
- Holding Companies
- Industry
- Financials
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 4,013,537
- Address
- 1720 Sublette Ave, ST. LOUIS, 63110-1927
- Web
- https://alliedmedicalllc.com/about/
- Phone
- +1 3147712400
- Auditors
- Rubin Brown LLP
Upcoming Events for AHPIQ
Similar to AHPIQ
1399 Internet Technology Application
Pink Sheets on Nasdaq
9 Meters Biopharma
Pink Sheets on Nasdaq
Absolute Health and Fitness
Pink Sheets on Nasdaq
ACC Aviation Holdings
Pink Sheets on Nasdaq
Access-Power & Co
Pink Sheets on Nasdaq
FAQ
As of Today at 18:12 UTC, shares in Allied Healthcare Products are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in Allied Healthcare Products last closed at $0.00 and the price had moved by -99% over the past 365 days. In terms of relative price strength the Allied Healthcare Products share price has underperformed the S&P500 Index by -99.19% over the past year.
There is no consensus recommendation for this security.
Find out moreAllied Healthcare Products does not currently pay a dividend.
Allied Healthcare Products does not currently pay a dividend.
Allied Healthcare Products does not currently pay a dividend.
To buy shares in Allied Healthcare Products you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in Allied Healthcare Products had a market capitalisation of $0.00m.
Here are the trading details for Allied Healthcare Products:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: AHPIQ
Based on an overall assessment of its quality, value and momentum Allied Healthcare Products is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Allied Healthcare Products. Over the past six months, its share price has underperformed the S&P500 Index by -99.09%.
As of the last closing price of $0.00, shares in Allied Healthcare Products were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Allied Healthcare Products PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Allied Healthcare Products' management team is headed by:
- John Weil - NEC
- Joseph Ondrus - PRE
- Daniel Dunn - CFO
- Susan Deuser - IND
- Judith Graves - IND
- Joseph Root - IND